[ASAP] CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer

Like
Liked

Date:

TOC Graphic

ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.4c21740
ALT-Lab-Ad-1

Recent Articles